-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Vertex Pharmaceuticals Inc / Ma quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
- Vertex Pharmaceuticals Inc / Ma Costs and Expenses for the quarter ending June 30, 2024 was $6.16B, a 320% increase year-over-year.
- Vertex Pharmaceuticals Inc / Ma Costs and Expenses for the twelve months ending June 30, 2024 was $10.7B, a 92.9% increase year-over-year.
- Vertex Pharmaceuticals Inc / Ma annual Costs and Expenses for 2023 was $6.04B, a 30.6% increase from 2022.
- Vertex Pharmaceuticals Inc / Ma annual Costs and Expenses for 2022 was $4.62B, a 3.53% decline from 2021.
- Vertex Pharmaceuticals Inc / Ma annual Costs and Expenses for 2021 was $4.79B, a 43.1% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)